Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT03043716

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

Conditions: Obstructive Sleep Apnea, Central Sleep Apnea, Mixed Sleep Apnea

Sex: All

Ages: 18 Years – 99 Years

Enrollment: 14147

Sponsor: ResMed

Location: Schlaf- und Beatmungszentrum Blaubeuren Blaubeuren Abbey Baden-Wurttemberg

Summary

Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients older than 18 years * New indication for a prescription of a Telemonitoring (AirViewTM)-capable ResMed PAP-device * Consent to use the telemonitoring System AirViewTM (ResMed GmbH \& Co KG) * Signed Informed Consent Exclusion Criteria: \- Pregnant and breastfeeding persons

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03043716). StuddyBuddy aggregates publicly available trial information.